SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 4,508.94 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 8,607.02 |
| Book Value / Share | 20.39 |
| Price / Book | n/a |
| NCAV ($M) | -7,070.67 |
| NCAV / Share | -16.75 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.01 |
| Return on Assets (ROA) | 0.01 |
| Return on Equity (ROE) | 0.02 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.01 |
| Current Ratio | 2.66 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 5,727.54 |
| Assets | 21,405.24 |
| Liabilities | 12,798.22 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 7,212.38 |
| Operating Income | 1,319.52 |
| Net Income | 156.92 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 902.17 |
| Cash from Investing | 886.67 |
| Cash from Financing | -1,358.72 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| GCAN – The Greater Cannabis Company, Inc. | GDERF – Galderma Group AG |
| GFOO – Genufood Energy Enzymes Corp. | GLPGF – Galapagos NV |
| GLUC – Glucose Health, Inc. |
Financial data and stock pages provided by
Fintel.io